These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 28905402)
1. Affinity capillary electrophoresis for the assessment of binding affinity of carbohydrate-based cholera toxin inhibitors. Aizpurua-Olaizola O; Sastre Torano J; Pukin A; Fu O; Boons GJ; de Jong GJ; Pieters RJ Electrophoresis; 2018 Jan; 39(2):344-347. PubMed ID: 28905402 [TBL] [Abstract][Full Text] [Related]
2. Picomolar inhibition of cholera toxin by a pentavalent ganglioside GM1os-calix[5]arene. Garcia-Hartjes J; Bernardi S; Weijers CA; Wennekes T; Gilbert M; Sansone F; Casnati A; Zuilhof H Org Biomol Chem; 2013 Jul; 11(26):4340-9. PubMed ID: 23689250 [TBL] [Abstract][Full Text] [Related]
3. Modifications of cholera toxin subunit B binding to human large intestinal epithelium. An immunohistochemical study. Kirkeby S; Lynge Pedersen AM Microb Pathog; 2018 Nov; 124():332-336. PubMed ID: 30145256 [TBL] [Abstract][Full Text] [Related]
11. Binding Cooperativity Matters: A GM1-Like Ganglioside-Cholera Toxin B Subunit Binding Study Using a Nanocube-Based Lipid Bilayer Array. Worstell NC; Krishnan P; Weatherston JD; Wu HJ PLoS One; 2016; 11(4):e0153265. PubMed ID: 27070150 [TBL] [Abstract][Full Text] [Related]
12. Solution dynamics of the oligosaccharide moiety of ganglioside GM1: comparison of solution conformations with the bound state conformation in association with cholera toxin B-pentamer. Richardson JM; Milton MJ; Homans SW J Mol Recognit; 1995; 8(6):358-62. PubMed ID: 9052976 [TBL] [Abstract][Full Text] [Related]
13. Conformational changes in cholera toxin B subunit-ganglioside GM1 complexes are elicited by environmental pH and evoke changes in membrane structure. McCann JA; Mertz JA; Czworkowski J; Picking WD Biochemistry; 1997 Jul; 36(30):9169-78. PubMed ID: 9230049 [TBL] [Abstract][Full Text] [Related]
14. Crystal structure of cholera toxin B-pentamer bound to receptor GM1 pentasaccharide. Merritt EA; Sarfaty S; van den Akker F; L'Hoir C; Martial JA; Hol WG Protein Sci; 1994 Feb; 3(2):166-75. PubMed ID: 8003954 [TBL] [Abstract][Full Text] [Related]
15. Synthesis of a photoreactive, radiolabelled derivative of the oligosaccharide of GM1 ganglioside. Pacuszka T; Fishman PH Glycobiology; 1992 Jun; 2(3):251-5. PubMed ID: 1498422 [TBL] [Abstract][Full Text] [Related]
16. Fighting Cholera One-on-One: The Development and Efficacy of Multivalent Cholera-Toxin-Binding Molecules. Zuilhof H Acc Chem Res; 2016 Feb; 49(2):274-85. PubMed ID: 26760438 [TBL] [Abstract][Full Text] [Related]
17. Cholera toxin inhibitors studied with high-performance liquid affinity chromatography: a robust method to evaluate receptor-ligand interactions. Bergström M; Liu S; Kiick KL; Ohlson S Chem Biol Drug Des; 2009 Jan; 73(1):132-41. PubMed ID: 19152642 [TBL] [Abstract][Full Text] [Related]
18. A 'catch-and-release' receptor for the cholera toxin. Mahon CS; Wildsmith GC; Haksar D; de Poel E; Beekman JM; Pieters RJ; Webb ME; Turnbull WB Faraday Discuss; 2019 Oct; 219(0):112-127. PubMed ID: 31313796 [TBL] [Abstract][Full Text] [Related]
19. GM1 clustering inhibits cholera toxin binding in supported phospholipid membranes. Shi J; Yang T; Kataoka S; Zhang Y; Diaz AJ; Cremer PS J Am Chem Soc; 2007 May; 129(18):5954-61. PubMed ID: 17429973 [TBL] [Abstract][Full Text] [Related]
20. Binding of cholera toxin B-subunits to derivatives of the natural ganglioside receptor, GM1. Lanne B; Schierbeck B; Angström J J Biochem; 1999 Jul; 126(1):226-34. PubMed ID: 10393343 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]